Moderna Inc (MIL:1MRNA)
€ 38.165 -0.445 (-1.15%) Market Cap: 14.61 Bil Enterprise Value: 9.32 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 44/100

Moderna Inc at Piper Sandler Healthcare Conference (Virtual) Transcript

Dec 01, 2021 / 07:00PM GMT
Edward Andrew Tenthoff
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

Good afternoon, everyone. My name is Ted Tenthoff. I'm a senior biotechnology analyst at Piper Sandler. Thanks for joining us for this year's Virtual Healthcare Conference. Sorry for the slight delay, but as you guys know, Stephen Hoge, President of Moderna literally is on the front lines of fighting Omicron. So we're going to jump right in.

Questions & Answers

Edward Andrew Tenthoff
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

Stephen, what can you tell us about this new variant and retain protection by the current vaccines?

Stephen Hoge
Moderna, Inc. - President

Well, first, I want to say thank you, Ted. We'll jump right in, of course. I do apologize to everybody for being a few minutes late here. As you can imagine, we're urgently dealing with some things related to Omicron, which makes us a very good starting question. So where -- we don't know yet, is the short

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot